ClearBridge Investments
BBNX

ClearBridge Investments’s Beta Bionics BBNX Stock Holding History

ClearBridge Investments’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-197,052
Closed -$3.92M – 746
2025
Q3 		$3.92M Sell
197,052
-52,682
-21% -$926K ﹤0.01% 608
2025
Q2 		$3.64M Sell
249,734
-119,491
-32% -$1.69M ﹤0.01% 592
2025
Q1 		$4.52M Buy
+369,225
New +$6.88M ﹤0.01% 573

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

ClearBridge Investments's BBNX Position: Q4 2025 in Review

ClearBridge Investments sold out of Beta Bionics (BBNX) in Q4 2025, closing a stake of 197,052 shares — an estimated $3.92M sold.

ClearBridge Investments first reported a position in BBNX in Q1 2025 and held it in 3 quarters. The position peaked at $4.52M in Q1 2025. 158 funds tracked by Wall St. Rank hold BBNX as of Q4 2025.

  • ClearBridge Investments reported no remaining Beta Bionics position as of Q4 2025 after selling out during the quarter.
  • ClearBridge Investments sold 197,052 Beta Bionics shares in Q4 2025, an estimated $3.92M.
  • ClearBridge Investments first reported a position in Beta Bionics in Q1 2025 and held it in 3 quarters.
  • ClearBridge Investments's Beta Bionics position peaked at $4.52M in Q1 2025.
  • 158 funds tracked by Wall St. Rank held Beta Bionics as of Q4 2025.

Based on ClearBridge Investments's 13F filing for Q4 2025, filed 11 Feb 2026.